You are here: Industry Insights > Dr Reddy’s

News List

Dr Reddy’s launches Roche’s Avastin biosimilar in India expresspharma
August 21, 2019
Drug firm Dr Reddy’s Laboratories said it has launched a biosimilar of Roche’s Avastin in India indicated for the treatment of various types of cancers. The company’s biosimilar, Versavo, is available in ...
New psoriasis drug study yields positive results: Dr Reddy’s expressbpd
June 14, 2019
According to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in future dermatology conferences
Indivior hit hard as generic Suboxone defence crumbles pharmaphorum
November 26, 2018
Indivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the door to generic competition and sparking a run on its shares.
DRL launches muscle disease drug in US financialexpress
September 13, 2018
The company’s product is the generic version of Bloxiverz Injection
Dr Reddy’s hit by yet another recall, of 80,000+ bottles pharmafiles
February 09, 2018
Dr Reddy’s has once again been slapped with a recall of over 80,000 bottles of Atorvastatin.
Dr Reddy’s posts Q4 and FY17 financial results financialexpress
May 15, 2017
In FY17, revenues were at Rs 140.8 billion and EBITDA at Rs 25.5 billion
US FDA to re-audit Dr Reddy’s three plants financialexpress
January 13, 2017
The plants are located at Srikakulam, Miryalaguda and Duvvada

Previous page 1 2 3 4 5 Next page